RxDoctor Payments Data

Matthew Ferroni, MD

Urology · Cedar Rapids, IANPI 1700171675

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.2%), travel and lodging and other — rather than concentrated in one kind of arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.8%. Reporting peaked in 2023 at $1,640 and has fallen 82.4% since, to $288 in 2025.

$5,068in general payments, 2019–2025

Across 79 payments — averaging $64.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neotract Inc.$1K
  • Valencia Technologies Corporation$972
  • Teleflex LLC$856
  • Astellas Pharma US Inc$280
  • Integra Lifesciences Corporation$279
  • Intuitive Surgical$222
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$2,26245%
  • Food & beverage$2,44248%
  • Education$852%
  • Other$2796%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,068 in reported general payments places this provider in the 75th percentile of 114 urology providers in Iowa.

See all urology providers in Iowa

Medicare billing

Part B allowed, 2024
$184,897
Medicare patients
350
Services billed
5,555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl513$7,853
Solifenacin Succinate148$4,698
Oxybutynin Chloride ErOxybutynin Chloride68$1,123
Finasteride108$1,046
Testosterone11$992
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst56$788
Testosterone Cypionate15$557
Oxybutynin Chloride53$399
Alfuzosin Hcl ErAlfuzosin Hcl17$228
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim48$175
Cephalexin19$145
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$134
Levofloxacin37$133
Ciprofloxacin Hcl16$101

Paid to pharmacies, not to this prescriber.

Other urology in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →